ENTITY

Eli Lilly & (LLY UN)

5
Analysis
Health CareUnited States
Eli Lilly and Company discovers, develops, manufactures, and sells pharmaceutical products for humans and animals. The Company products are sold in countries around the world. Eli Lilly products include neuroscience, endocrine, anti-infectives, cardiovascular agents, oncology, and animal health products.
more
bullishEli Lilly & Co
27 Dec 2024 17:00

Eli Lilly's Weight Loss Revolution: Is It Edging Out Novo Nordisk?

In a pivotal moment for the weight-loss and anti-obesity market, Eli Lilly & Co. has solidified its leadership position following...

Logo
440 Views
Share
bullishEli Lilly & Co
07 Nov 2024 18:00

How Eli Lilly Plans to Conquer the GLP-1 Market – And Why Investors Should Pay Attention!

Eli Lilly and Company's third-quarter earnings for 2024 present a composite picture of the pharmaceutical giant's current performance and future...

Logo
208 Views
Share
bullishBeta Bionic
23 Jan 2025 06:24

Beta Bionics IPO: Will The Innovative MedTech Company Repeat The Success of Livongo Health?

Beta Bionics, a developer of bionic pancreas system called iLet, is expected to IPO next week. In my insight, I discuss IPO valuation and...

Logo
25 Views
Share
22 Jan 2025 20:53Issuer-paid

Biopharma Week in Review - January 21, 2025

M&A and preannouncements led biopharma headlines last week, with nearly $20 billion in deals fueling some positive sentiment, but disappointing...

Logo
113 Views
Share
bullishEli Lilly & Co
12 May 2024 03:00

Eli Lilly & Co: The Story Behind The Increasing Demand vs. Production of Orforglipron & Progress of Other Drugs! - Major Drivers

In Q1 2024, Eli Lilly and Company achieved strong growth and strategic milestones, with revenue growing by 26% and new products increasing by...

Logo
329 Views
Share
x